Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

por Joerger, Markus, Calvo, Emiliano, Laubli, Heinz, Lopez, Juanita, Alonso, Guzmán, Corral de la Fuente, Elena, Hess, Dagmar, König, David, Sanchez Perez, Vicky, Bucher, Christoph, Jethwa, Sangeeta, Garralda, Elena
Publicado 2023